<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="34623" end="34628" sStart="33650" offset="979" sid="r7.1.use.v.0530" wn="1" wnkey="use%2:34:01::" annotator="jeneale" text="The following files are available with the online version of this article: expression datasets of the cell culture and xenograft profiles as a tab-delimited text file (Additional data file 1); a spreadsheet file including extra data, such as the scale-normalized means prior to quantile normalization, p -values from the 'present' test, a sheet of data from 60 control probe-sets on the Affymetrix chips, and data from the mouse lung tissue control profile (Additional data file 2); the search results for significantly enriched classes for GO annotation (Additional data file 3) and for MeSH term literature associations (Additional data file 4) for genes found to significantly differ at p &lt; 0.01, fold change &gt; 2 between tumors and cell cultures for a given cell line; the values used in the classifications of cell culture lineage using xenograft tumor profiles, together with the classification results, which correctly predicted the lineage of all six cell culture profiles, as an Excel spreadsheet (Additional data file 5)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="15067" end="15072" sStart="null" offset="262" sid="r11.refer.v.0915" wn="6" wnkey="refer%2:32:00::" annotator="adelpriore" text="Sp1 is important for the basal expression of various collagens, and blocking Sp1 broadly inhibits expression of ECM genes [ 8 ] . Terms such as 'Pathologic neovascularization' (13,9) and 'Vascular endothelium' (29,26) can refer to processes of angiogenesis, the generation of new blood vessels from preexisting vessels for the delivery of nutrients to tumors." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="22851" end="22855" sStart="null" offset="100" sid="r7.poor.j.0052" wn="4" wnkey="poor%3:00:02::" annotator="veweser" text="First, profiling mouse tissue alone using probe sets designed for human genes gives poor hybridization, to the extent that the contribution from mouse genes would not have been enough to account for the differences in gene expression observed." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="22851" end="22855" sStart="null" offset="100" sid="r7.poor.j.0052" wn="5" wnkey="poor%5:00:00:insufficient:00" annotator="jeneale" text="First, profiling mouse tissue alone using probe sets designed for human genes gives poor hybridization, to the extent that the contribution from mouse genes would not have been enough to account for the differences in gene expression observed." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="22851" end="22855" sStart="null" offset="100" sid="r7.poor.j.0052" wn="5" wnkey="poor%5:00:00:insufficient:00" annotator="cgozo" text="First, profiling mouse tissue alone using probe sets designed for human genes gives poor hybridization, to the extent that the contribution from mouse genes would not have been enough to account for the differences in gene expression observed." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="22851" end="22855" sStart="null" offset="100" sid="r7.poor.j.0052" wn="5" wnkey="poor%5:00:00:insufficient:00" annotator="brubin" text="First, profiling mouse tissue alone using probe sets designed for human genes gives poor hybridization, to the extent that the contribution from mouse genes would not have been enough to account for the differences in gene expression observed." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="751" end="755" sStart="null" offset="201" sid="null" wn="1" wnkey="kill%2:35:00::" annotator="veweser" text="The effects of these environmental differences on cancer cells may account, in part, for the fact that only a small percentage of anticancer drugs that are found to effectively kill cells in vitro are successful in subsequent animal and human studies." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="751" end="755" sStart="null" offset="201" sid="null" wn="1" wnkey="kill%2:35:00::" annotator="sophiavv" text="The effects of these environmental differences on cancer cells may account, in part, for the fact that only a small percentage of anticancer drugs that are found to effectively kill cells in vitro are successful in subsequent animal and human studies." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="751" end="755" sStart="null" offset="201" sid="null" wn="1" wnkey="kill%2:35:00::" annotator="cgozo" text="The effects of these environmental differences on cancer cells may account, in part, for the fact that only a small percentage of anticancer drugs that are found to effectively kill cells in vitro are successful in subsequent animal and human studies." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="751" end="755" sStart="null" offset="201" sid="null" wn="1" wnkey="kill%2:35:00::" annotator="brubin" text="The effects of these environmental differences on cancer cells may account, in part, for the fact that only a small percentage of anticancer drugs that are found to effectively kill cells in vitro are successful in subsequent animal and human studies." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="751" end="755" sStart="null" offset="201" sid="null" wn="1" wnkey="kill%2:35:00::" annotator="bpassonneau" text="The effects of these environmental differences on cancer cells may account, in part, for the fact that only a small percentage of anticancer drugs that are found to effectively kill cells in vitro are successful in subsequent animal and human studies." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="751" end="755" sStart="null" offset="201" sid="null" wn="3" wnkey="kill%2:30:08::" annotator="anfahmy" text="The effects of these environmental differences on cancer cells may account, in part, for the fact that only a small percentage of anticancer drugs that are found to effectively kill cells in vitro are successful in subsequent animal and human studies." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="751" end="755" sStart="null" offset="201" sid="r9.kill.v.0826" wn="1" wnkey="kill%2:35:00::" annotator="anfahmy" text="The effects of these environmental differences on cancer cells may account, in part, for the fact that only a small percentage of anticancer drugs that are found to effectively kill cells in vitro are successful in subsequent animal and human studies." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="2042" end="2047" sStart="null" offset="10" sid="r8.1.great.j.0813" wn="1" wnkey="great%5:00:01:large:00" annotator="veweser" text="Whereas a great deal of genetic variability exists among different tumors from different patients, lesser genetic heterogeneity would be expected in xenografts of cancer cells originally derived from a single patient." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="4873" end="4877" sStart="null" offset="165" sid="r9.fold.v.0085" wn="2147483645" wnkey="null" annotator="veweser" text="Between the A549 xenograft tumors and the A549 cell cultures, 357 genes (375 probe sets) differed significantly at p &lt; 0.01 with a fold change greater than two either way (134 genes being higher in tumors and 223 genes being higher in culture), a number much greater than the 24 to be expected by chance, as determined by permutation testing." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="10182" end="10186" sStart="null" offset="445" sid="r9.fold.v.0043" wn="2147483645" wnkey="null" annotator="veweser" text="Searches were made for significantly enriched gene classes, as defined by Gene Ontology (GO) annotation or Medical Subject Heading Index (MeSH) term association (see Materials and methods), for both the set of 223 genes upregulated in the A549 cell cultures over A549 tumors and the set of 256 genes upregulated in the U118 cell cultures over the U118 tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="12300" end="12304" sStart="null" offset="141" sid="r9.fold.v.0035" wn="2147483645" wnkey="null" annotator="veweser" text="A search for enriched gene classes was also made for 157 genes that were expressed more highly ( p &lt; 0.05, fold change &gt; 2) in both A549 and U118 cell cultures over tumors, and the significant classes found were the same, or of the same nature, as the classes listed in Table 2. For the entire set of enriched classes for genes upregulated in cell cultures over the xenograft tumors, including which genes belong to which classes, see Additional data files and [ 7 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="17001" end="17005" sStart="null" offset="241" sid="r9.fold.v.0031" wn="2147483646" wnkey="null" annotator="veweser" text="By comparison, 46 genes (over four times the 10 expected by chance) were common to the 223 genes upregulated in A549 cultures and the 256 genes upregulated in U118 cultures over tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="13242" end="13246" sStart="null" offset="269" sid="r9.fold.v.0439" wn="2147483645" wnkey="null" annotator="cgozo" text="As with the genes expressed at higher levels in culture compared to xenografts, searches were made for significantly enriched GO and MeSH term classes for the set of 134 genes with significantly higher expression ( p &lt; 0.01, fold change &gt; 2) in the A549 tumors over the A549 cell cultures and the set of 112 genes upregulated in the U118 tumors over the U118 cell cultures." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="4873" end="4877" sStart="null" offset="165" sid="r9.fold.v.0085" wn="2147483645" wnkey="null" annotator="cgozo" text="Between the A549 xenograft tumors and the A549 cell cultures, 357 genes (375 probe sets) differed significantly at p &lt; 0.01 with a fold change greater than two either way (134 genes being higher in tumors and 223 genes being higher in culture), a number much greater than the 24 to be expected by chance, as determined by permutation testing." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="10182" end="10186" sStart="null" offset="445" sid="r9.fold.v.0043" wn="2147483645" wnkey="null" annotator="cgozo" text="Searches were made for significantly enriched gene classes, as defined by Gene Ontology (GO) annotation or Medical Subject Heading Index (MeSH) term association (see Materials and methods), for both the set of 223 genes upregulated in the A549 cell cultures over A549 tumors and the set of 256 genes upregulated in the U118 cell cultures over the U118 tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="12300" end="12304" sStart="null" offset="141" sid="r9.fold.v.0035" wn="2147483645" wnkey="null" annotator="cgozo" text="A search for enriched gene classes was also made for 157 genes that were expressed more highly ( p &lt; 0.05, fold change &gt; 2) in both A549 and U118 cell cultures over tumors, and the significant classes found were the same, or of the same nature, as the classes listed in Table 2. For the entire set of enriched classes for genes upregulated in cell cultures over the xenograft tumors, including which genes belong to which classes, see Additional data files and [ 7 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="17001" end="17005" sStart="null" offset="241" sid="r9.fold.v.0031" wn="2147483645" wnkey="null" annotator="cgozo" text="By comparison, 46 genes (over four times the 10 expected by chance) were common to the 223 genes upregulated in A549 cultures and the 256 genes upregulated in U118 cultures over tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="9221" end="9225" sStart="null" offset="135" sid="r9.fold.v.0200" wn="2147483645" wnkey="null" annotator="brubin" text="Of the 134 genes found expressed more highly in A549 xenograft tumors over A549 cultures ( p &lt; 0.01, fold change &gt; 2), 70 were also higher in stage I adenocarcinomas over A549 cultures ( p &lt; 0.05)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="4873" end="4877" sStart="null" offset="165" sid="r9.fold.v.0085" wn="2147483645" wnkey="null" annotator="brubin" text="Between the A549 xenograft tumors and the A549 cell cultures, 357 genes (375 probe sets) differed significantly at p &lt; 0.01 with a fold change greater than two either way (134 genes being higher in tumors and 223 genes being higher in culture), a number much greater than the 24 to be expected by chance, as determined by permutation testing." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="10182" end="10186" sStart="null" offset="445" sid="r9.fold.v.0043" wn="2147483645" wnkey="null" annotator="brubin" text="Searches were made for significantly enriched gene classes, as defined by Gene Ontology (GO) annotation or Medical Subject Heading Index (MeSH) term association (see Materials and methods), for both the set of 223 genes upregulated in the A549 cell cultures over A549 tumors and the set of 256 genes upregulated in the U118 cell cultures over the U118 tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="12300" end="12304" sStart="null" offset="141" sid="r9.fold.v.0035" wn="2147483645" wnkey="null" annotator="brubin" text="A search for enriched gene classes was also made for 157 genes that were expressed more highly ( p &lt; 0.05, fold change &gt; 2) in both A549 and U118 cell cultures over tumors, and the significant classes found were the same, or of the same nature, as the classes listed in Table 2. For the entire set of enriched classes for genes upregulated in cell cultures over the xenograft tumors, including which genes belong to which classes, see Additional data files and [ 7 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="17001" end="17005" sStart="null" offset="241" sid="r9.fold.v.0031" wn="2147483645" wnkey="null" annotator="brubin" text="By comparison, 46 genes (over four times the 10 expected by chance) were common to the 223 genes upregulated in A549 cultures and the 256 genes upregulated in U118 cultures over tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="4873" end="4877" sStart="null" offset="165" sid="r9.fold.v.0085" wn="2147483645" wnkey="null" annotator="anfahmy" text="Between the A549 xenograft tumors and the A549 cell cultures, 357 genes (375 probe sets) differed significantly at p &lt; 0.01 with a fold change greater than two either way (134 genes being higher in tumors and 223 genes being higher in culture), a number much greater than the 24 to be expected by chance, as determined by permutation testing." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="10182" end="10186" sStart="null" offset="445" sid="r9.fold.v.0043" wn="" wnkey="null" annotator="anfahmy" text="Searches were made for significantly enriched gene classes, as defined by Gene Ontology (GO) annotation or Medical Subject Heading Index (MeSH) term association (see Materials and methods), for both the set of 223 genes upregulated in the A549 cell cultures over A549 tumors and the set of 256 genes upregulated in the U118 cell cultures over the U118 tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="12300" end="12304" sStart="null" offset="141" sid="r9.fold.v.0035" wn="" wnkey="null" annotator="anfahmy" text="A search for enriched gene classes was also made for 157 genes that were expressed more highly ( p &lt; 0.05, fold change &gt; 2) in both A549 and U118 cell cultures over tumors, and the significant classes found were the same, or of the same nature, as the classes listed in Table 2. For the entire set of enriched classes for genes upregulated in cell cultures over the xenograft tumors, including which genes belong to which classes, see Additional data files and [ 7 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="17001" end="17005" sStart="null" offset="241" sid="r9.fold.v.0031" wn="" wnkey="null" annotator="anfahmy" text="By comparison, 46 genes (over four times the 10 expected by chance) were common to the 223 genes upregulated in A549 cultures and the 256 genes upregulated in U118 cultures over tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="10566" end="10571" sStart="null" offset="108" sid="r10.find.v.0629" wn="4" wnkey="find%2:32:00::" annotator="veweser" text="For example, for the A549 set of 223 genes, 35 enriched LocusLink annotation terms were found that had a p -value less than 1.9E-03, where one term with a p -value less than 1.9E-03 would be expected in a given set of 223 randomly selected genes." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="19969" end="19973" sStart="null" offset="83" sid="r7.1.face.n.0446" wn="2147483645" wnkey="null" annotator="jeneale" text="In contrast, cells in a tumor growing in a host tissue environment face conditions with more limited nutrients and oxygen and are subjected to or benefit from a wide variety of host factors." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="17229" end="17238" sStart="null" offset="200" sid="null" wn="1" wnkey="different%3:00:00::" annotator="veweser" text="Whereas processes of cell division and metabolism may be more in common from one cancer to the next, processes of cell adhesion and ECM interaction are likely to be very different between different cell types." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="21303" end="21312" sStart="null" offset="148" sid="r8.1.different.j.0929" wn="1" wnkey="different%3:00:00::" annotator="veweser" text="In terms of new biological insight into cancer development, our findings suggest that cancer cells of different origins interact in different ways with the same extracellular environment to survive and proliferate as tumors." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="1201" end="1210" sStart="null" offset="4" sid="r8.1.different.j.0561" wn="4" wnkey="different%5:00:01:other:00" annotator="veweser" text="Two different cell lines were studied: A549, derived from human lung adenocarcinoma, and U118, derived from human brain glioblastoma." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="23043" end="23052" sStart="null" offset="8" sid="r8.1.different.j.0277" wn="4" wnkey="different%5:00:01:other:00" annotator="veweser" text="Second, different cell adhesion and ECM-related genes are upregulated in tumors of different cell types (A549 versus U118); if the upregulation were due to a common mouse source, then the same genes should have appeared upregulated in both cell types, given that the cells were grown in the same site." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="17229" end="17238" sStart="null" offset="200" sid="null" wn="1" wnkey="different%3:00:00::" annotator="jeneale" text="Whereas processes of cell division and metabolism may be more in common from one cancer to the next, processes of cell adhesion and ECM interaction are likely to be very different between different cell types." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="17229" end="17238" sStart="null" offset="200" sid="null" wn="2" wnkey="different%5:00:00:other:00" annotator="cgozo" text="Whereas processes of cell division and metabolism may be more in common from one cancer to the next, processes of cell adhesion and ECM interaction are likely to be very different between different cell types." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="21700" end="21709" sStart="null" offset="288" sid="r8.1.different.j.0939" wn="1" wnkey="different%3:00:00::" annotator="brubin" text="These lineage-specific genetic programs for cell adhesion and ECM interaction, although less active in cell culture, are not lost, but may be reactivated when cells are transplanted back into an in vivo environment, even if the new environment is different from the tissue of origin of the cancer." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="2097" end="2106" sStart="null" offset="65" sid="r8.1.different.j.0671" wn="4" wnkey="different%5:00:01:other:00" annotator="brubin" text="Whereas a great deal of genetic variability exists among different tumors from different patients, lesser genetic heterogeneity would be expected in xenografts of cancer cells originally derived from a single patient." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="35483" end="35490" sStart="null" offset="232" sid="r10.control.n.0533" wn="4" wnkey="control%1:09:02::" annotator="veweser" text="The scale-normalized means prior to quantile normalization, p -values from the 'present' test, a sheet of data from 60 control probe-sets on the Affymetrix chips, and data from the mouse lung tissue control profile" />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="4089" end="4095" sStart="null" offset="31" sid="r10.common.j.0765" wn="1" wnkey="common%3:00:02::" annotator="veweser" text="Gene classes can be defined by common gene annotations or concepts from the biomedical literature." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="17104" end="17110" sStart="null" offset="75" sid="r10.common.j.0787" wn="3" wnkey="common%5:00:00:shared:00" annotator="cgozo" text="Whereas processes of cell division and metabolism may be more in common from one cancer to the next, processes of cell adhesion and ECM interaction are likely to be very different between different cell types." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="30458" end="30464" sStart="null" offset="23" sid="r10.common.j.0818" wn="2147483646" wnkey="null" annotator="anfahmy" text="For a given gene class common to n genes within the k set, where the class applied to a total of A genes out of the entire set of G unique genes under study, the probability, p , for the term occurring n or more times within a set of k genes randomly selected from the chip was calculated using the one-sided Fisher's exact test." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="23209" end="23215" sStart="null" offset="174" sid="r10.common.j.0746" wn="3" wnkey="common%5:00:00:shared:00" annotator="anfahmy" text="Second, different cell adhesion and ECM-related genes are upregulated in tumors of different cell types (A549 versus U118); if the upregulation were due to a common mouse source, then the same genes should have appeared upregulated in both cell types, given that the cells were grown in the same site." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="1678" end="1684" sStart="null" offset="78" sid="r10.common.j.0362" wn="2147483646" wnkey="null" annotator="anfahmy" text="We looked for in vivo versus in vitro differences that were common to the two cell lines, and for differences that were found in one cell line but not the other." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="4039" end="4045" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" annotator="veweser" text="Such clues could be especially convincing if it can be shown that the enriched classes are unlikely to represent a &lt;b&gt;chance&lt;/b&gt; occurrence." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="5069" end="5075" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" annotator="veweser" text="Between the A549 xenograft tumors and the A549 cell cultures, 357 genes (375 probe sets) differed significantly at p &lt; 0.01 with a fold change greater than two either way (134 genes being higher in tumors and 223 genes being higher in culture), a number much greater than the 24 to be expected by &lt;b&gt;chance&lt;/b&gt;, as determined by permutation testing." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="4039" end="4045" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="tofox" text="Such clues could be especially convincing if it can be shown that the enriched classes are unlikely to represent a &lt;b&gt;chance&lt;/b&gt; occurrence." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="16833" end="16839" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tofox" text="By comparison, 46 genes (over four times the 10 expected by &lt;b&gt;chance&lt;/b&gt;) were common to the 223 genes upregulated in A549 cultures and the 256 genes upregulated in U118 cultures over tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="16833" end="16839" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" annotator="comcgeetubb" text="By comparison, 46 genes (over four times the 10 expected by &lt;b&gt;chance&lt;/b&gt;) were common to the 223 genes upregulated in A549 cultures and the 256 genes upregulated in U118 cultures over tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="16833" end="16839" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="chisom" text="By comparison, 46 genes (over four times the 10 expected by &lt;b&gt;chance&lt;/b&gt;) were common to the 223 genes upregulated in A549 cultures and the 256 genes upregulated in U118 cultures over tumors ( p &lt; 0.01, fold change &gt; 2)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="5069" end="5075" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" annotator="carichter" text="Between the A549 xenograft tumors and the A549 cell cultures, 357 genes (375 probe sets) differed significantly at p &lt; 0.01 with a fold change greater than two either way (134 genes being higher in tumors and 223 genes being higher in culture), a number much greater than the 24 to be expected by &lt;b&gt;chance&lt;/b&gt;, as determined by permutation testing." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="3644" end="3650" sStart="null" offset="65" sid="r9.appear.v.0821" wn="1" wnkey="appear%2:39:00::" annotator="veweser" text="These are classes or functional categories of genes that appear overrepresented in the set of differentially expressed genes." />
    <s path="[OANC]/data/written_2/technical/biomed/gb-2003-4-7-r46.anc" start="29831" end="29839" sStart="null" offset="77" sid="r9.appear.v.0170" wn="1" wnkey="appear%2:39:00::" annotator="anfahmy" text="We removed from further consideration any MeSH term that appeared to have no relevance to our study (for example, MeSH terms describing experimental protocols or the healthcare system)." />
  </sentences>
</list>